Detalles de la búsqueda
1.
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Int J Mol Sci
; 25(6)2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38542211
2.
Incidence and predictors of infections in patients with advanced non-small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study.
Scand J Immunol
; 98(3): e13303, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38441223
3.
Smoking Prevalence, Knowledge and Perceptions on Tobacco Control Among Healthcare Professionals: A Survey in an Italian Cancer Center.
J Community Health
; 46(3): 597-602, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789714
4.
Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer.
Int J Mol Sci
; 22(21)2021 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34769372
5.
What Are the Biomarkers for Immunotherapy in SCLC?
Int J Mol Sci
; 22(20)2021 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681779
6.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474768
7.
Breath Analysis: Comparison among Methodological Approaches for Breath Sampling.
Molecules
; 25(24)2020 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33321824
8.
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review.
J Clin Med
; 12(5)2023 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902620
9.
A CT-based transfer learning approach to predict NSCLC recurrence: The added-value of peritumoral region.
PLoS One
; 18(5): e0285188, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130116
10.
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Cancers (Basel)
; 15(20)2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894419
11.
Informative Power Evaluation of Clinical Parameters to Predict Initial Therapeutic Response in Patients with Advanced Pleural Mesothelioma: A Machine Learning Approach.
J Clin Med
; 11(6)2022 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35329985
12.
Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decade.
Thorac Cancer
; 13(24): 3486-3495, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36333988
13.
[Efficacy of pralsetinib in a patient with advanced lung adenocarcinoma positive for RET rearrangement: the importance of Comprehensive Genomic Profiling.] / Efficacia di pralsetinib in un paziente con adenocarcinoma polmonare in stadio avanzato positivo per riarrangiamento di RET: l'importanza del Comprehensive Genomic Profiling.
Recenti Prog Med
; 112(1): 10e-13e, 2021 01.
Artículo
en Italiano
| MEDLINE | ID: mdl-33512367
14.
Immune Checkpoint Inhibitors in Advanced NSCLC: [18F]FDG PET/CT as a Troubleshooter in Treatment Response.
Diagnostics (Basel)
; 11(9)2021 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34574022
15.
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib.
Thorac Cancer
; 12(13): 2031-2034, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34008923
16.
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features.
Cancers (Basel)
; 13(12)2021 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34208253
17.
Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study.
Open Forum Infect Dis
; 8(6): ofab187, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34141817
18.
Psychological well-being in cancer outpatients during COVID-19.
J BUON
; 26(3): 1127-1134, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34268981
19.
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy.
Clin Lung Cancer
; 22(2): e180-e192, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33162330
20.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
JAMA Oncol
; 7(12): 1856-1861, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734989